Estimated prevalence of polysaccharide storage myopathy among overtly healthy Quarter Horses in the United States
- PMID: 17764437
- DOI: 10.2460/javma.231.5.746
Estimated prevalence of polysaccharide storage myopathy among overtly healthy Quarter Horses in the United States
Abstract
Objective: To estimate the prevalence of polysaccharide storage myopathy (PSSM) among Quarter Horses in the United States and evaluate possible relationships between muscle glycogen concentration, turnout time, and exercise level.
Design: Cross-sectional study.
Animals: 164 overtly healthy Quarter Horses > 2 years old from 5 states.
Procedures: Horses with a history of exertional rhabdomyolysis or any other muscular disease were excluded. Muscle biopsy specimens were examined histologically for evidence of PSSM and were submitted for determination of muscle glycogen concentration. A diagnosis of PSSM was made if amylase-resistant inclusions that stained with periodic acid-Schiff stain were detected.
Results: Prevalences of PSSM on the 2 farms with a history of PSSM were 20% (1/5) and 40.7% (11/27); mean prevalence for the other 4 farms was 6.1% (8/132). Sex was not significantly associated with a diagnosis of PSSM, and age was not significantly different between horses with and without PSSM. Total histologic score, serum creatine kinase activity, and muscle glycogen concentration were significantly higher in horses with PSSM than in horses without.
Conclusions and clinical relevance: Results suggested that the prevalence of PSSM among overtly healthy Quarter Horses in the United States is likely to be between 6% and 12%.
Similar articles
-
Proglycogen, macroglycogen, glucose, and glucose-6-phosphate concentrations in skeletal muscles of horses with polysaccharide storage myopathy performing light exercise.Am J Vet Res. 2006 Sep;67(9):1589-94. doi: 10.2460/ajvr.67.9.1589. Am J Vet Res. 2006. PMID: 16948606
-
Prevalences and clinical signs of polysaccharide storage myopathy and shivers in Belgian draft horses.J Am Vet Med Assoc. 2005 Dec 15;227(12):1958-64. doi: 10.2460/javma.2005.227.1958. J Am Vet Med Assoc. 2005. PMID: 16379634
-
Prevalence of polysaccharide storage myopathy in horses with neuromuscular disorders.Equine Vet J Suppl. 2006 Aug;(36):340-4. doi: 10.1111/j.2042-3306.2006.tb05565.x. Equine Vet J Suppl. 2006. PMID: 17402444
-
Polysaccharide Storage Myopathy.Vet Clin North Am Equine Pract. 2025 Apr;41(1):125-137. doi: 10.1016/j.cveq.2024.11.004. Epub 2025 Jan 31. Vet Clin North Am Equine Pract. 2025. PMID: 39893126 Review.
-
Equine diseases caused by known genetic mutations.Vet J. 2009 Mar;179(3):336-47. doi: 10.1016/j.tvjl.2008.03.016. Epub 2008 May 9. Vet J. 2009. PMID: 18472287 Review.
Cited by
-
Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis.Genomics. 2008 May;91(5):458-66. doi: 10.1016/j.ygeno.2008.01.011. Epub 2008 Mar 20. Genomics. 2008. PMID: 18358695 Free PMC article.
-
Gene expression profiling in equine polysaccharide storage myopathy revealed inflammation, glycogenesis inhibition, hypoxia and mitochondrial dysfunctions.BMC Vet Res. 2009 Aug 7;5:29. doi: 10.1186/1746-6148-5-29. BMC Vet Res. 2009. PMID: 19664222 Free PMC article.
-
Metabolic disorders in foals.Equine Vet Educ. 2012 Aug;24(8):392-395. doi: 10.1111/j.2042-3292.2011.00376.x. Epub 2012 Feb 20. Equine Vet Educ. 2012. PMID: 32313388 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources